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LNo man’s land: Ischemic mitral regurgitation after primary
percutaneous coronary interventionChristina M. Vassileva, MD,a and Maurice Enriquez-Sarano, MDbMitral regurgitation (MR) complicates the course of 13% to
50% of acute myocardial infarctions (MI).1 Postinfarction
(ischemic) MR (IMR) portends a poor prognosis during
long-term follow-up and has been identified as an indepen-
dent predictor of heart failure (HF) and reduced long-term
survival.2 Moreover, the severity of IMR is related to ad-
verse outcomes in a graded manner; increasing IMR
(none vs mild vs moderate to severe) is associated with
decreased 1- and 5-year survival rates.2,3 In 1 study, which
excluded patients who were older than 65 years, who had
previous MI, multiple comorbidities, or severe congestive
heart failure, 19% of patients had MR at 5 to 8 weeks after
the event.4 Even in these young and relatively healthy
patients after first MI, mortality at 15 months was 3 times
higher for patients with IMR compared with those without
IMR (9.8% vs 3.2%). In addition, HF developed relatively
rapidly, and by 15 months, 20% of patients with IMR had
mild to moderate HF compared with 3% of patients without
IMR.4
Timely reperfusion is the primary goal of therapy for
acute ST-elevation MI (STEMI). In the current era, this is
best accomplished by percutaneous coronary intervention
(PCI) when resources are available. In addition, PCI is in-
creasingly performed in the setting of non–ST-elevation
MI (NSTEMI). Although our focus on revascularization
strategies has brought about progress in the field of cardio-
vascular medicine, we have paid less attention to other is-
sues at hand, such as the assessment of left ventricular
(LV) function or MR after MI. Thus, we have limited our
ability to give full consideration to possible therapies that
may alleviate the HF that occurs at a persistently high rate
after MI. Although current guidelines recommend assess-
ment of LV function in the setting of acute MI, preproce-
dural screening for the presence of IMR is not performed
in most patients referred for primary PCI, unless it is sec-
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Despite the poor prognosis with chronic IMR after pri-
mary PCI, there are no established guidelines for the routine
follow-up of these patients. In fact, a recent survey of more
than 1000 cardiovascular specialists from the United States
and worldwide demonstrated that 25% did not even
evaluate for the presence of IMR at the time of PCI.5 This
percentage was as high as 32% in some regions of the
United States.5 Improvement and even resolution of IMR
may be expected after primary PCI in some cases. On the
other hand, the absence of IMR at the initial presentation
does not ensure freedom from IMR on longer-term fol-
low-up because the post-MI LV remodeling may occur
over several months or years. Unlike IMR in the coronary
artery bypass graft population, little is known about the fac-
tors that may influence progression of IMR after primary
PCI.
The most important strategy to ameliorate LV remodel-
ing after MI remains early reperfusion. Theoretically, early
reperfusion should halt the process of LV remodeling and
the subsequent development of IMR. Indeed, there are
some anecdotal reports from the 1980s of resolution of
IMR with reperfusion alone.6,7 In general, successful
reperfusion with primary PCI does not predictably result
in improvement of IMR.8 In 43% of patients with IMR after
first acute MI, IMR was still present 10 days later and was
unrelated to the patency of the culprit vessel.7 Longer-term
studies at 1, 2, and 3 months, and up to 1 year, demonstrate
that IMR persists in many patients.4,8
The most recent American College of Cardiology/Amer-
ican Heart Association focused update of the management
of patients with valvular heart disease does not specifically
address the subset of patients with IMR after primary
PCI.9 This gap may be largely because of the paucity of
data on these patients to allow the development of practice
guidelines. We know that IMR is functional and is associ-
ated with poor outcome, but many uncertainties remain.
We have not developed a uniform nomenclature of positive
signs that allow us to link the MR to ischemic heart disease.
Moreover, we have not uniformly accepted criteria of sever-
ity specific to IMR.We know that IMRmay regress or prog-
ress, but we have not developed prevalence data in the
chronic phase after MI and have not developed mechanistic
factors that lead to the progression/regression of the IMR.
Although IMR is a common complication of MI, the exact
frequency with which it is detected largely depends on the
modality used to look for its presence and the timing withy c July 2013
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Lrespect to the acute MI. In earlier published studies, using
angiography to document IMR, it was reported to occur in
13% to 19% of patients with acute MI.3 Subsequent studies
using mainly color Doppler echocardiography report IMR
with higher frequency, between 35% and 74%.1,2,8 The
definition of chronic IMR with respect to the timing of
the MI has also varied among studies. In the seminal
work from the Survival and Ventricular Enlargement
(SAVE) trial, Lamas and colleagues3 defined the early
post-MI phase of IMR as fewer than 16 days after MI. Sub-
sequently, Grigioni and colleagues2 coined the term chronic
IMR to denote MR present for longer than 16 days after MI.
Others have suggested that IMR may appear up to 6 weeks
after MI as the LV undergoes remodeling.
The heterogeneity between study populations makes
meaningful comparisons difficult. The available studies
that include echocardiographic examination of patients after
primary PCI can largely be divided into 2 subsets: (1) those
that assess IMR early at some point after the MI event and
subsequently provide long-term clinical follow-up and
(2) those that provide serial echocardiographic data and
correlate the presence and/or severity of IMR to clinical out-
comes.Most studies fall into the first category,with echocar-
diographic examination provided within 30 days after the
MI and no subsequent studies for comparison.1,6,7 Few
studies report on long-term echocardiographic evaluation
of patients after acute MI.2 These studies lack information
on the presence and severity of IMR at the time of MI, but
include a single echocardiographic assessment months to
years after the index event and compare the clinical out-
comes of patients with and without IMR.2 There are 2 serial
echocardiographic studies in patients with acute MI under-
going PCI; in one, most patients were treated medically or
underwent thrombolysis, and the second study was small
and included only 2 serial echocardiographic examinations,
one at the time of MI and the second 3 months after the
event.3,5
Despite the differences in study design and the heteroge-
neity of the patient populations, all reports consistently
indicate that IMR after primary PCI portends a poor prog-
nosis, with a reported 5-year mortality of 40% to 55%.1
Yet, the most recent American College of Cardiology Foun-
dation/American Heart Association updates of the guide-
lines on the management of patients with NSTEMI or
STEMI do not address the issue of IMR, except for acute
papillary muscle rupture. Furthermore, although evaluation
of ventricular function is emphasized, the use of echocardi-
ography is not required, provided left ventriculography isThe Journal of Thoracic andperformed at the time of PCI. In a recent study of 5380 res-
idents of the Worcester, Mass, metropolitan area who were
admitted for acute MI between 1997 and 2005, 47% of the
patients did not receive echocardiography (20% had an
ejection fraction evaluation by left ventriculography,
whereas the other 27% did not have an ejection fraction
evaluation) in 2005.10 Essential work remains to be done
in terms of prevalence, mechanism, nomenclature, progres-
sion, outcome, and treatment of IMR. There appears to be
an important need for the development of evidence-based
guidelines for the follow-up of patients with acute MI
treated with primary PCI, specifically addressing risk strat-
ification with respect to IMR progression, and recommen-
dations regarding optimal frequency of echocardiographic
follow-up and timing mitral valve repair for IMR.
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